Pixantrone
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Also known as: pixantrone dimaleate, pixantrone maleate, pixuvri
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Pixantrone is a drug catalogued in DrugCentral. It was first approved by the EMA in 2012. Recorded indications include Non-Hodgkin's lymphoma.
- Indications: Non-Hodgkin's lymphoma.
- ATC code: L01DB11 (Anthracyclines and related substances).
- Molecular formula: C17H19N5O2; molecular weight 325.37 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Non-Hodgkin's lymphoma
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 2012-05-10 | EMA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
L01DB11 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS › ANTINEOPLASTIC AGENTS › CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES › Anthracyclines and related substances |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Disease progression | 141.8 |
Chemical structure
| Molecular formula | C17H19N5O2 |
|---|---|
| Molecular weight | 325.37 g/mol |
| CAS number | 144675-97-8 |
| InChIKey | PEZPMAYDXJQYRV-UHFFFAOYSA-N |
| PubChem CID | 134019 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Pixantrone used for?
DrugCentral lists the following indications for Pixantrone: Non-Hodgkin's lymphoma.
When was Pixantrone first approved?
Pixantrone was first approved by the EMA in 2012.
What is the chemical formula of Pixantrone?
Pixantrone has the molecular formula C17H19N5O2 and a molecular weight of 325.37 g/mol.
Browse: all drugs starting with P · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4330 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL167731 — compound record and bioactivity
- PubChem CID 134019 — chemical identifiers
- DrugBank DB06193 — drug record
- FDA UNII F5SXN2KNMR — substance identity
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.